Harry Glorikian, Angel Investor

Harry Glorikian is an AI‑driven health investor, author, and board director, serving as General Partner at a New York-based VC firm. Since 2017, he has backed entrepreneurs leveraging computational biology and digital health technologies to reshape diagnostics, drug discovery, and patient care, with portfolio companies achieving IPOs and strategic exits. He is also a seasoned technologist and operator, known for transforming complex, real‑world data into actionable insights. His emphasis on transparency and explainability reflects his belief that trust and precision are essential when both patient outcomes and investment returns are at stake. Beyond investing, Harry is an author, speaker, and podcast host, spotlighting innovators through his books MoneyBall Medicine and The Future You, as well as The Harry Glorikian Show. As an angel investor, he has backed Emerald and MarketMuse, underscoring his commitment to advancing healthcare innovation and data‑driven solutions.